Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsTherapeutic antibody development is often hindered by high inter-subject variability, suboptimal tissue distribution, and rapid clearance. Creative Biolabs' Pharmacokinetics Optimization Services address these critical challenges through a multifaceted approach. We employ advanced strategies including sequence engineering, pH-dependent antibody recycling design, and precision glycan optimization. This integrated methodology ensures the generation of superior drug candidates with enhanced half-lives, improved biodistribution, and robust clinical translatability, accelerating your lead from discovery to the clinic.
Optimizing antibody pharmacokinetics (PK) is crucial for advancing therapeutic biologics. Despite clinical success, challenges like high variability, limited tissue distribution, and complex PK of novel formats (e.g., bispecifics) hinder efficacy and dosing. Mechanistic PK/PD modeling has become essential, integrating physiological and molecular insights to elucidate key determinants, such as FcRn recycling and target-mediated disposition, and to guide the rational design of next-generation antibodies with optimized biodistribution and target engagement.
Fig.1 Key challenges and evolving strategies in therapeutic antibody PK/PD model development.1
Creative Biolabs offers comprehensive Pharmacokinetics Optimization Services designed to refine the serum persistence, stability, and biodistribution of therapeutic antibodies. By employing advanced Fc engineering and glycan modification strategies, we overcome challenges such as target-mediated drug disposition (TMDD) and rapid clearance. Our tailored solutions provide clients with optimized antibody candidates exhibiting enhanced FcRn-mediated recycling, minimized off-target binding, and improved pharmacokinetic profiles to accelerate therapeutic development.
To address the critical interplay between antibody glycosylation and pharmacokinetics, we offer tailored optimization services that focus on specific glycan modifications. These services enable precise control over antibody half-life, stability, and effector function to meet distinct therapeutic requirements.
This service focuses on modulating the terminal glycosylation profile of therapeutic antibodies by enhancing their sialic acid content. Increased sialylation effectively masks underlying galactose residues, thereby reducing recognition and clearance by hepatic asialoglycoprotein receptors (ASGPR). This strategy is particularly valuable for extending the serum half-life of glycoprotein therapeutics, improving their exposure and efficacy in chronic disease settings such as autoimmune disorders and enzyme replacement therapies.
Learn More →Our service provides precise control over galactose residues on antibody N-glycans to fine-tune effector functions and pharmacokinetic behavior. By optimizing galactosylation levels, we can modulate antibody-dependent cellular cytotoxicity (ADCC) potency while maintaining favorable systemic stability and ensuring consistent engagement with FcγRIIIa on immune cells. This balance is essential for developing oncology antibodies, where both strong effector function and prolonged circulation are required for optimal therapeutic outcomes.
Learn More →Required Starting Materials: To begin the service, please supply either the amino acid sequence of the lead candidate or the purified protein sample, accompanied by its known target-binding affinity data.
Key Steps:
Final Deliverables: Upon completion, we will deliver a detailed Optimization Summary Report, which includes comparative PK profiles, sequence maps of the engineered variants, and high-purity recombinant protein samples for further evaluation.
Our Pharmacokinetics Optimization Services deliver targeted solutions that balance prolonged half-life with maintained bioactivity. By integrating deep learning-driven variant screening and precision glycoengineering, we systematically identify rare, high-performance mutations and remove immunogenic glycans to prevent rapid clearance. This enables the development of candidates with superior, industry-validated pharmacokinetic profiles.
"The PK Optimization service critically enhanced our monovalent antibody fragment's duration of action. Precisely engineered Fc mutations achieved a threefold increase in serum half-life versus the native construct." Dr. Al**son.
"Deep learning-aided specificity screening refined our ADC's targeting accuracy. Strategic modifications to the variable domain substantially reduced off-target liver uptake, markedly improving the therapeutic index." Prof. Marc**et.
We offer a comprehensive Antibody Glyco Optimization Services portfolio, encompassing a range of tailored solutions. A key component of this suite is our Pharmacokinetics Optimization service, which leverages precise glycoengineering strategies to unlock superior in vivo pharmacokinetic properties for your therapeutic antibodies, including extended half-life, improved tissue distribution, and enhanced stability. Please contact us to initiate a project consultation and receive a customized collaboration proposal.
Reference
1. Tang, Yu, and Yanguang Cao. "Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions." Pharmaceutics vol. 13,3 422. Distributed under an Open Access License CC BY 4.0, without modification. https://doi.org/10.3390/pharmaceutics13030422.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
